> Clinical Enrollments
> Clinical Results
> Drug Approvals
> Drug Licensing
> Medical Devices
We provide online services that help organizations turn information into insight. We specialize in Web-based solutions for:
- targeted market research
- increased sales productivity
- optimized business analysis
Our turnkey products and customized solutions help business managers at all levels in an organization effectively manage large amounts of data and disseminate knowledge. As a result, their people can quickly capitalize on critical business opportunities.
The primary factors contributing to Infinata’s success, as well as the success of our clients, are our:
- in-house research capabilities and proprietary data
- industry-specific knowledge for each target market
- easily configured Web-based software and database technology
- flexible and scalable applications that clients can adapt to changing business requirements
History of BioPharm Insight [PDF]
Brief history of Infinata
Infinata, part of The Mergermarket Group, is an unparalleled, independent intelligence company used by the world's foremost companies to increase business and land new clients. It provides proprietary intelligence on individuals and companies allowing for new sales and partnership opportunities via social networking.
Incorporated in 1999 it has since become the fastest growing business in its sector. As well as expanding its coverage and adding new products, the company continues to launch ground-breaking products and services.
Infinata is part of the Financial Times Group, publisher of the Financial Times newspaper and FT.com. FT Group is a division of Pearson plc, the international media group.